You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Peru Patent: 20170773


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20170773

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,426,782 Jun 23, 2035 Day One Biopharms OJEMDA tovorafenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20170773

Last updated: August 1, 2025


Introduction

Peru Patent PE20170773 is a patent granted within the Peruvian territory, ostensibly related to a pharmaceutical compound or formulation, and embodies a strategic asset for its holder, likely aimed at specific therapeutic indications or innovative delivery mechanisms. To accurately evaluate its commercial and legal potential, a comprehensive review of its scope, claims, and the broader patent landscape is necessary.


Patent Overview

Peru Patent PE20170773 was filed and granted in 2017, representing an innovation in the pharmaceutical domain. While specific bibliographic details are not explicitly provided in the prompt, typical characteristics of such patents include detailed descriptions of novel compounds, formulations, or uses thereof that aim to address unmet medical needs or improve existing therapies.


Scope of the Patent

The scope of PE20170773 is primarily delineated by its claims—the boundaries that define the intellectual property rights conferred. In pharmaceuticals, the scope typically ranges from broad claims covering a class of compounds or formulations to narrow claims targeting specific molecules, dosages, or methods of use.

  1. Type of Patent:

    • Likely a compound patent, claiming a specific chemical entity or a set of chemical structures.
    • Alternatively, it could be a formulation patent—covering a unique drug delivery system or stabilized composition.
    • Or, a use patent, protecting specific therapeutic applications.
  2. Claim Coverage:

    • If the patent includes broad chemical structure claims, it could encompass a wide array of derivatives, serving to prevent competitors from developing similar compounds within the same structural class.
    • Narrow claims, such as specific compound salts, dosages, or administration routes, limit the scope but strengthen enforceability against infringing entities.
  3. Legal and Practical Implications:

    • Patents with broad claims provide extensive protective coverage, potentially covering primary research discoveries.
    • Narrow claims may be more defensible but offer limited protection.

Analysis of Patent Claims

While the exact text of the claims is necessary for precise analysis, standard considerations include:

  • Independent Claims:

    • Likely describe the core invention, specifying the chemical structure, composition, or method.
    • For example, "A compound of formula X, or a pharmaceutically acceptable salt or ester thereof."
  • Dependent Claims:

    • Refine the independent claims by specifying particular variants, formulations, or methods of preparation.
    • Provide fallback positions in legal disputes, offering tit-for-tat protections.
  • Scope and Breadth:

    • If the independent claims cover a broad chemical class, competitors might design around the patent by modifying structures or delivery methods.
    • Conversely, narrow claims restrict competitive activity but are easier to defend.
  • Novelty & Inventive Step:

    • The claims should demonstrate novelty over prior art and an inventive step, which is critical given the patent landscape.

Patent Landscape Analysis

Understanding the broader patent landscape involves analyzing existing patents and patent applications to determine the novelty, freedom to operate, and patent thickets.

  1. Prior Art Search:

    • The patent’s novelty hinges on a thorough prior art analysis.
    • Likely references include existing chemical patents, WO patents, and other regional filings.
  2. Related Patents and Patent Families:

    • Peruvian patents are often part of larger international patent families.
    • Search of related patent families reveals whether the invention has broader protection outside Peru, in jurisdictions like the US, Europe, or China.
  3. Competitive Landscape:

    • Major pharmaceutical companies, biotech firms, and generics players are active in the same therapeutic areas.
    • Patent filings in neighboring countries may impact enforcement and licensing strategies.
  4. Patent Term and Market Entry:

    • Given the filing date (~2017), the patent is likely valid until approximately 2037, assuming standard 20-year patent terms.
    • This grants a significant barrier to generic entry within Peru.
  5. Potential Challenges and Risks:

    • If similar patents exist, the scope of PE20170773 might face validity challenges based on anticipation or obviousness.
    • Patentability assessments should include chemical novelty, inventive nuances, and patent law specifics.

Legal Status and Enforcement

  • Grant Status:

    • As a granted patent, PE20170773 provides enforceable rights within Peru, including potential injunctions against infringing parties and damages recovery.
  • Extension and Maintenance:

    • Maintenance fees must be paid periodically to keep the patent active.
    • Its enforceability is contingent on timely maintenance.
  • Potential Oppositions:

    • Peruvian patent law allows for opposition or invalidation actions within certain periods post-grant, which may be strategically employed by competitors or patent authorities.

Implications for Stakeholders

  • Pharmaceutical Developers:

    • The patent protects the core innovation, suggesting market exclusivity, which can be leveraged for commercialization or licensing.
    • Competitors must either design around the claims or challenge validity.
  • Legal and Patent Strategists:

    • The scope of the claims indicates the strength and breadth of protection.
    • Investigating similar patents and prior art ensures comprehensive freedom-to-operate assessments.
  • Regulatory and Commercial Teams:

    • Patent protection aligns with regulatory approval timelines, market entry strategies, and pricing models.

Conclusion

Peru Patent PE20170773 exemplifies strategic intellectual property protection within the pharmaceutical domain, with its scope primarily governed by its claims. The breadth of these claims influences the patent’s enforceability and commercial value, while the surrounding patent landscape indicates a competitive environment with potential for both collaboration and litigation. A careful legal and technical review, including claim analysis and prior art searches, is essential for stakeholders aiming to maximize the patent’s value and navigate the regional pharmaceutical patent terrain.


Key Takeaways

  • The scope of PE20170773 critically depends on its independent claims; broad claims confer extensive protection but may face validity challenges.
  • The patent landscape around similar compounds or formulations in Peru and international markets influences the patent’s strength and potential for litigation or licensing.
  • Ongoing maintenance, potential opposition, and legal challenges can impact the patent’s enforceability and market exclusivity.
  • Strategic patent claim drafting and landscape analysis are vital for commercial success and minimizing infringement risks.
  • Integration with regulatory strategies enhances the overall value of the patent portfolio.

FAQs

  1. What is the main therapeutic focus of Peru Patent PE20170773?

    • The specific therapeutic area or indications are not provided here; detailed patent documents would clarify whether it relates to oncology, infectious diseases, or other medical fields.
  2. How does the scope of claims affect patent enforceability?

    • Broader claims are more potent in preventing competitors from developing similar products but may be more susceptible to validity challenges. Narrow claims are safer but offer limited protection.
  3. Can this patent be challenged or invalidated?

    • Yes, through legal proceedings like oppositions or infringement suits, especially if prior art demonstrates lack of novelty or inventive step.
  4. What is the significance of the patent landscape surrounding PE20170773?

    • It provides insight into potential competition, opportunities for licensing, and possible patent infringements.
  5. How can stakeholders maximize the value of this patent?

    • By conducting detailed claim and landscape analyses, ensuring strategic patent prosecution, and integrating patent protection with regulatory and commercial plans.

References

[1] Peru National Institute of Intellectual Property. Official Patent Database.
[2] World Intellectual Property Organization (WIPO). Patent Scope Database.
[3] Patent Law of Peru, Law No. 26282.
[4] European Patent Office. Patent Search and Examination Procedures.
[5] Patent Landscape Reports for Pharmaceutical Innovations, Industry Sources.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.